Celldex Therapeutics shares owned by Crestline Management
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Crestline Management
from 13F filings
Historical chart of Crestline Management investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Crestline Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Crestline Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $7.5M | 295k | 25.27 |
| 2024-09-30 | $4.7M | 138k | 33.99 |
| 2024-03-31 | $2.9M | 69k | 41.97 |
| 2023-12-31 | $2.7M | 67k | 39.66 |
| 2023-09-30 | $1.7M | 63k | 27.52 |
| 2023-06-30 | $1.4M | 42k | 33.93 |
| 2023-03-31 | $1.1M | 30k | 35.98 |
| 2022-12-31 | $1.6M | 36k | 44.57 |
| 2022-09-30 | $1.1M | 40k | 28.10 |
| 2022-06-30 | $1.0M | 38k | 26.96 |
| 2022-03-31 | $1.1M | 32k | 34.06 |
More positions owned by Crestline Management
View all positions for Crestline Management